Why Is HIMS & HERS HEALTH I A (HIMS) Stock Moving Today?
By the Top Tier Newswire AI Desk · September 8, 2026 at 4:30 AM ET · reviewed against 3 wire stories
HIMS & HERS HEALTH I A (HIMS) is drawing unusual attention today. Our newswire has captured 3 stories on HIMS across 3 sources in the last 36 hours, with AI sentiment reading bearish (avg 33/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
HIMS stock is moving lower by 9.1% over the last eight sessions as a securities class action lawsuit is filed against the company and its executives. The lawsuit follows a federal complaint from the Federal Trade Commission that has raised investor concerns about corporate practices. The stock has fallen from $30.34 to $27.59 amid legal uncertainty and a deteriorating sentiment trend.
What Happened
A class action lawsuit was filed against Hims & Hers Health, Inc. and certain executives, citing the FTC’s federal complaint as the catalyst. The legal action alleges investor harm and is being pursued by Bronstein, Gewirtz & Grossman LLC, a law firm specializing in investor rights. The lawsuit was announced through multiple press releases, with the most recent filing appearing on September 7, 2026. The company now faces potential regulatory and financial consequences, which have contributed to the stock’s decline.
What The Data Shows
The stock has traded within a 52-week range of $13.74 to $65.30, with a current market cap of $6.5 billion. Despite revenue growth of 28.0% in the trailing twelve months, the company remains unprofitable with an EPS of -0.62 and a net margin of -5.5%. The stock’s beta of 2.41 indicates high volatility. Over the past 90 days, insiders have sold 12 times, totaling $7.3 million, with no insider purchases recorded. The stock has seen no social media chatter in the last 24 hours and only two posts in the past seven.
What To Watch
Investors should monitor the legal developments surrounding the class action lawsuit. A key deadline for investors to participate in the action is November 2, 2026.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
HIMS · Sep 8 session (5-min) · +1.52% vs prior close · updated 9:00 PM ETAI sentiment, last 36h · averaged over 3 stories · 33/100 bearish
The headlines behind the move
Story flow · 3 stories on the wire, last 36h · hover or tap a dot for the headline
5d agoPR NewswireBEARISH 32General
Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS
SAN FRANCISCO, Sept. 7, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business...
5d agoGlobeNewswireBEARISH 34General
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
NEW YORK, Sept. 6, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of its officers. This lawsuit seeks to recover...
6d agoBarchartBEARISH 34General
Hims & Hers Health, Inc. (HIMS) Class Action Lawsuit: Investors Face November 2, 2026, Deadline
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →